학술논문
Final Results from a Phase I Trial Combining Selinexor with High-Dose Cytarabine (HiDAC) and Mitoxantrone (Mito) for Remission Induction in Acute Myeloid Leukemia (AML)
Document Type
Abstract
Author
Source
In Blood 29 November 2018 132 Supplement 1:4073-4073
Subject
Language
ISSN
0006-4971